Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313648630> ?p ?o ?g. }
- W4313648630 endingPage "728" @default.
- W4313648630 startingPage "715" @default.
- W4313648630 abstract "Overexpression of Lin28 is detected in various cancers with involvement in the self-renewal process and cancer stem cell generation. In the present study, we evaluated how the Lin28 axis plays an immune-protective role for tumor-initiating cancer cells in hepatocellular carcinoma (HCC). Our result using HCC patient samples showed a positive correlation between indoleamine 2,3-dioxygenase-1 (IDO1), a kynurenine-producing enzyme with effects on tumor immune escape, and Lin28B. Using in silico prediction, we identified a Sox2/Oct4 transcriptional motif acting as an enhancer for IDO1. Knockdown of Lin28B reduced Sox2/Oct4 and downregulated IDO1 in tumor-initiating hepatic cancer cells. We further observed that inhibition of Lin28 by a small-molecule inhibitor (C1632) suppressed IDO1 expression. Suppression of IDO1 resulted in a decline in kynurenine production from tumor-initiating cells. Inhibition of the Lin28 axis also impaired PD-L1 expression in HCC cells. Consequently, modulating Lin28B enhanced in vitro cytotoxicity of glypican-3 (GPC3)-chimeric antigen receptor (CAR) T and NK cells. Next, we observed that GPC3-CAR T cell treatment together with C1632 in a HCC xenograft mouse model led to enhanced anti-tumor activity. In conclusion, our results suggest that inhibition of Lin28B reduces IDO1 and PD-L1 expression and enhances immunotherapeutic potential of GPC3-CART cells against HCC." @default.
- W4313648630 created "2023-01-07" @default.
- W4313648630 creator A5002785191 @default.
- W4313648630 creator A5020200414 @default.
- W4313648630 creator A5027940255 @default.
- W4313648630 creator A5030143515 @default.
- W4313648630 creator A5039232082 @default.
- W4313648630 creator A5065594317 @default.
- W4313648630 creator A5070690016 @default.
- W4313648630 date "2023-03-01" @default.
- W4313648630 modified "2023-10-18" @default.
- W4313648630 title "Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell population" @default.
- W4313648630 cites W1579787255 @default.
- W4313648630 cites W1838472703 @default.
- W4313648630 cites W1950176298 @default.
- W4313648630 cites W1973700890 @default.
- W4313648630 cites W1984484036 @default.
- W4313648630 cites W1986533360 @default.
- W4313648630 cites W1987525605 @default.
- W4313648630 cites W1990376085 @default.
- W4313648630 cites W1991713904 @default.
- W4313648630 cites W2010608530 @default.
- W4313648630 cites W2030714059 @default.
- W4313648630 cites W2035123149 @default.
- W4313648630 cites W2038225686 @default.
- W4313648630 cites W2060070314 @default.
- W4313648630 cites W2066364577 @default.
- W4313648630 cites W2075325752 @default.
- W4313648630 cites W2087016406 @default.
- W4313648630 cites W2088514277 @default.
- W4313648630 cites W2118290853 @default.
- W4313648630 cites W2120054052 @default.
- W4313648630 cites W2123986423 @default.
- W4313648630 cites W2126908586 @default.
- W4313648630 cites W2127799088 @default.
- W4313648630 cites W2137672147 @default.
- W4313648630 cites W2148114118 @default.
- W4313648630 cites W2152951302 @default.
- W4313648630 cites W2166222776 @default.
- W4313648630 cites W2166425625 @default.
- W4313648630 cites W2417156540 @default.
- W4313648630 cites W2419090891 @default.
- W4313648630 cites W2509153611 @default.
- W4313648630 cites W2511723471 @default.
- W4313648630 cites W2514392303 @default.
- W4313648630 cites W2591521756 @default.
- W4313648630 cites W2598998146 @default.
- W4313648630 cites W2613581156 @default.
- W4313648630 cites W2905892207 @default.
- W4313648630 cites W2911120459 @default.
- W4313648630 cites W2912181843 @default.
- W4313648630 cites W2965390074 @default.
- W4313648630 cites W2968014226 @default.
- W4313648630 cites W2998854007 @default.
- W4313648630 cites W2999031113 @default.
- W4313648630 cites W3006120968 @default.
- W4313648630 cites W3010301137 @default.
- W4313648630 cites W3016811071 @default.
- W4313648630 cites W3023954831 @default.
- W4313648630 cites W3040062773 @default.
- W4313648630 cites W3096611073 @default.
- W4313648630 cites W3097722171 @default.
- W4313648630 cites W3119005666 @default.
- W4313648630 cites W3124631812 @default.
- W4313648630 cites W3126439695 @default.
- W4313648630 cites W3139549049 @default.
- W4313648630 cites W3152534107 @default.
- W4313648630 cites W3154612073 @default.
- W4313648630 cites W3180754516 @default.
- W4313648630 cites W3185786839 @default.
- W4313648630 cites W3198705972 @default.
- W4313648630 cites W3206510554 @default.
- W4313648630 cites W3210792018 @default.
- W4313648630 cites W3216852569 @default.
- W4313648630 cites W4210774372 @default.
- W4313648630 cites W4211183069 @default.
- W4313648630 cites W4213435562 @default.
- W4313648630 doi "https://doi.org/10.1016/j.ymthe.2023.01.002" @default.
- W4313648630 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36609146" @default.
- W4313648630 hasPublicationYear "2023" @default.
- W4313648630 type Work @default.
- W4313648630 citedByCount "1" @default.
- W4313648630 countsByYear W43136486302023 @default.
- W4313648630 crossrefType "journal-article" @default.
- W4313648630 hasAuthorship W4313648630A5002785191 @default.
- W4313648630 hasAuthorship W4313648630A5020200414 @default.
- W4313648630 hasAuthorship W4313648630A5027940255 @default.
- W4313648630 hasAuthorship W4313648630A5030143515 @default.
- W4313648630 hasAuthorship W4313648630A5039232082 @default.
- W4313648630 hasAuthorship W4313648630A5065594317 @default.
- W4313648630 hasAuthorship W4313648630A5070690016 @default.
- W4313648630 hasConcept C104317684 @default.
- W4313648630 hasConcept C107459253 @default.
- W4313648630 hasConcept C121608353 @default.
- W4313648630 hasConcept C126322002 @default.
- W4313648630 hasConcept C145103041 @default.
- W4313648630 hasConcept C173396325 @default.
- W4313648630 hasConcept C185592680 @default.